← Back to headlines
Eli Lilly Explores Pain Management Strategy with New Biotech Acquisition
Eli Lilly and Company is reportedly strengthening its pain management strategy through a new acquisition of a biotech firm.
24 Jun, 13:26 — 24 Jun, 13:26
Sources
Showing 1 of 1 sources
